Stock MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
7.24 USD +3.28% Intraday chart for Maravai LifeSciences Holdings, Inc. -3.72% +10.53%
06-12 Maravai Lifesciences Holdings, Inc. Announces Resignation of Anat Ashkenazi as Director, Effective July 31,2024 CI
06-11 Transcript : Maravai LifeSciences Holdings, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 01:20 PM

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Applied DNA and Alphazyme Conclude Linea RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea IVT Platform Economics
AQ
Maravai LifeSciences : Management Change/Compensation Form 8 K
PU
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
BU
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
GL
Maravai LifeSciences : Conflict Minerals Statement
PU
Maravai LifeSciences : Q1 2024 Earnings
PU
Maravai LifeSciences Reports First Quarter 2024 Financial Results
GL
TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology
AQ
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
BU
TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
AQ
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
BU
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
GL
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
AQ
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
GL
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
AQ
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
AQ
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
GL
TriLink BioTechnologies Solidifies IP Position with Awarded Patents for CleanCap Capping Technology in China and Canada
AQ
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
BU
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MRVI Stock
  4. News Maravai LifeSciences Holdings, Inc.
  5. Press Releases